CIRM Turning to 'Dramatic' Increases in Therapeutic Research
What direction is the $3 billion California stem cell agency going to take in the coming year and beyond?
As CIRM Chairman Robert Klein put it, how is the four-year-old enterprise going to respond to a "changing scientific landscape of stem cell science as well as the evolving thinking of the board and of CIRM’s staff and many stakeholders?".
Is the emph…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.